MTCM
OCDX

Mint Tower Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Mint Tower Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-49,953
Closed -$932K – 473
2022
Q1 		$932K Buy
49,953
+35,564
+247% +$640K 0.09% 192
2021
Q4 		$308K Buy
+14,389
New +$284K 0.04% 264

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mint Tower Capital Management's OCDX Position: Q2 2022 in Review

Mint Tower Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 49,953 shares — an estimated $932K sold.

Mint Tower Capital Management first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $932K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Mint Tower Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Mint Tower Capital Management sold 49,953 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $932K.
  • Mint Tower Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Mint Tower Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $932K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Mint Tower Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.